Search

Unlocking the power of simulation: a next generation solution to training ophthalmic professionals

With experts predicting that global blindness will triple by 2050, and the number of people requiring eyecare already outpacing the number of trained ophthalmologists, eyecare training has never been more vital. Traditional in-person ophthalmic training has been curtailed by the...

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

Oriel celebrates breaking ground milestone

A special breaking ground celebration was held on 11 July to mark the start of construction to build Oriel, a new eyecare, research and education centre in Camden.

Eye scans detect signs of Parkinson’s disease up to seven years before diagnosis

A team led by Siegfried Wagner and Pearse Keane of Moorfields Eye Hospital and UCL Institute of Ophthalmology (and spanning UCL institutions) has identified markers that indicate the presence of Parkinson’s disease in patients on average seven years before clinical presentation.

World-first artificial intelligence foundation model for eye care to supercharge global efforts to prevent blindness

Researchers at Moorfields Eye Hospital and UCL Institute of Ophthalmology (IoO) have developed an artificial intelligence (AI) system that has the potential to not only identify sight-threatening eye diseases but also predict general health, including heart attacks, stroke and Parkinson’s disease.

Landmark review of glaucoma treatment and research published by Moorfields-led team

Four world-leading experts, including Hari Jayaram and Gus Gazzard from Moorfields, have combined their knowledge with the findings from over 150 peer-reviewed study publications to produce a landmark paper published in the Lancet.

UKISCRS 47th Annual Congress Preview

Check out the Eye News preview for UKISCRS' 47th Annual Congress in London, 1-3 November.

OSA Insights to Market win praise from members

OSA members praised the breadth of optical market insights provided by the Autumn meeting this week as a broad spectrum of suppliers gathered in London, reinforcing the strength of the trade body.

The Eyes Have It launches new report calling for a National Eye Care Plan for England to address surging patient demand

The Eyes Have It is a partnership of Macular Society, Fight for Sight / Vision Foundation, Royal National Institute of Blind People (RNIB), Association of Optometrists, The Royal College of Ophthalmologists and Roche Products Ltd.

The Worshipful Company Of Spectacle Makers closes 2023 with 9 new liverymen and 1 new court assistant

The Worshipful Company of Spectacle Makers brought a successful 2023 to a close with the admission of 9 new Liverymen at its December Court Lunch.

Don’t miss Optometry Tomorrow 2024

There is still time to register for the College of Optometrists’ flagship event, Optometry Tomorrow.

Age and gender impacts effectiveness of new gene therapy treatments for eye diseases, new study finds

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular Therapy, reveal how age and gender affects inflammation caused by gene...